Ruxolitinib early administration reduces acute GVHD after alternative donor hematopoietic stem cell transplantation in acute leukemia

Abstract This study aimed to observe the safety and clinical efficacy of early application of ruxolitinib to prevent acute graft-versus-host disease (aGVHD) after alternative donor transplantation in acute leukemia. There were 57 patients undergoing allo-HSCT at the Affiliated Cancer Hospital of Zhe...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Binglei Zhang, Lingyun Chen, Jian Zhou, Yingling Zu, Ruirui Gui, Zhen Li, Juan Wang, Fengkuan Yu, Yanli Zhang, Huifang Zhao, Zhenyu Ji, Yongping Song
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Nature Portfolio 2021-04-01
Schriftenreihe:	Scientific Reports
Online-Zugang:	https://doi.org/10.1038/s41598-021-88080-3
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!